Dr. Meredith Hay won a $5.7 million grant for clinical trials on a novel peptide therapy that, if successful, would be the first drug to treat vascular dementia – the second most common form of dementia.
UArizona President Dr. Robert C. Robbins said the university expected to see an increase in COVID-19 cases, but it has become too much, necessitating a shelter-in-place recommendation similar to what the state faced in the spring.
Efforts to keep patients safe in the time of COVID-19 led to significant savings and innovation in chemotherapy delivery and earned University of Arizona Health Sciences center national recognition.
Joining the University of Arizona Health Sciences in October, Dr. Geoffrey Rubin holds six U.S. patents for medical image analysis and is past chairman of radiology at Duke University School of Medicine.
A study by University of Arizona Health Sciences researchers found that green light therapy resulted in about a 60% reduction in the pain intensity of the headache phase and number of days per month people experienced migraine headaches.
Dr. Theresa Dr. Cullen, director of the Pima County Health Department, said the county, university and other partners are working together on a “layered approach” to COVID-19 mitigation.
The university will conduct 5,000 COVID-19 tests per week as part of continued efforts to slow the spread of the virus.
The antibody test determines who has been exposed to and developed an immune response against COVID-19.
Arizona Center for Drug Discovery and University of Arizona Cancer Center host Sept. 15 virtual summit to discuss new innovations in drug discovery to benefit citizens throughout the state and more.
Dr. Fayez K. Ghishan, director of the Steele Children’s Research Center, will hold the Fayez K. Ghishan, MD, PANDA Endowed Directorship.
UArizona Athletics Dave Heeke and Drs. Daniel Derksen and Dr. Janko Nikolich-Žugich will headline this unique livestream presentation of the Arthritis Center’s annual educational fundraiser.
Inappropriate medications – such as oleandrin, a derivative of oleander known to be toxic – used to prevent or treat COVID-19 could cause significant harm and no benefit, University of Arizona Health Sciences-based center and Banner Health center warn.
Bolstered by a $1.6 million grant, Dr. Timothy Bolger, at the University of Arizona Cancer Center, is studying how cells respond to stress and the role this process has in cancer growth and aging.
A University of Arizona Health Sciences cohort study of more than 50,000 menopausal women showed significant decrease in Alzheimer’s disease diagnosis.
Drs. Leslie Farland and Melanie Bell at the UArizona Mel and Enid Zuckerman College of Public Health to lead a federally funded research study to investigate a link among endometriosis, infertility and stroke in women.
Free and open to the public, the livestreamed online lecture by University of Arizona Arthritis Center Director Dr. C. Kent Kwoh will focus on the mechanisms of stem cell and Platelet-Rich Plasma therapies to treat osteoarthritis.
UArizona and Covid Watch Launch COVID-19 Exposure Notification App
Drs. Arka Chatterjee, Talal Moukabary and Madhan Sundaram bring significant expertise in interventional cardiology and electrophysiology to the Sarver Heart Center and Banner – University Medicine Tucson.
A new federal grant ensures the Pediatric Pulmonary Center at the University of Arizona Health Sciences will continue building skills of health-care providers to care for such children and their families.
The University of Arizona’s Dr. Maria Altbach is working with industry to improve MRI detection of liver tumor spread to expand therapeutic options and improve survival of colorectal cancer patients.